AQR Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.62M | Buy |
|
|||||
|
2025
Q1 | $3.84M | Buy |
|
|||||
|
2024
Q4 | $1.57M | Buy |
|
|||||
|
2024
Q3 | $814K | Buy |
|
|||||
|
2024
Q2 | $511K | Buy |
|
|||||
|
2024
Q1 | $379K | Sell |
|
|||||
|
2023
Q4 | $547K | Sell |
|
|||||
|
2023
Q3 | $945K | Buy |
|
|||||
|
2023
Q2 | $1.27M | Buy |
|
|||||
|
2023
Q1 | $904K | Sell |
|
|||||
|
2022
Q4 | $946K | Sell |
|
|||||
|
2022
Q3 | $1.33M | Buy |
|
|||||
|
2022
Q2 | $832K | Sell |
|
|||||
|
2022
Q1 | $1.99M | Sell |
|
|||||
|
2021
Q4 | $2.6M | Buy |
|
|||||
|
2021
Q3 | $1.68M | Buy |
|
|||||
|
2021
Q2 | $1.26M | Buy |
|
|||||
|
2021
Q1 | $581K | Sell |
|
|||||
|
2020
Q4 | $647K | Sell |
|
|||||
|
2020
Q3 | $1.26M | Sell |
|
|||||
|
2020
Q2 | $1.86M | Buy |
|
|||||
|
2020
Q1 | $2M | Sell |
|
|||||
|
2019
Q4 | $6.15M | Sell |
|
|||||
|
2019
Q3 | $8.58M | Buy |
|
|||||
|
2019
Q2 | $6.15M | Sell |
|
|||||
|
2019
Q1 | $8.85M | Sell |
|
|||||
|
2018
Q4 | $9.41M | Sell |
|
|||||
|
2018
Q3 | $16.4M | Buy |
|
|||||
|
2018
Q2 | $12.7M | Sell |
|
|||||
|
2018
Q1 | $10.9M | Sell |
|
|||||
|
2017
Q4 | $13M | Buy |
|
|||||
|
2017
Q3 | $9.2M | Buy |
|
|||||
|
2017
Q2 | $5.5M | Sell |
|
|||||
|
2017
Q1 | $6.37M | Sell |
|
|||||
|
2016
Q4 | $6.01M | Buy |
|
|||||
|
2016
Q3 | $6.63M | Buy |
|
|||||
|
2016
Q2 | $3.52M | Buy |
|
|||||
|
2016
Q1 | $2.7M | Buy |
|
|||||
|
2015
Q4 | $1.88M | Sell |
|
|||||
|
2015
Q3 | $11.8M | Sell |
|
|||||
|
2015
Q2 | $28.5M | Sell |
|
|||||
|
2015
Q1 | $41.2M | Sell |
|
|||||
|
2014
Q4 | $51.4M | Buy |
|
|||||
|
2014
Q3 | $49.5M | Sell |
|
|||||
|
2014
Q2 | $55.1M | Buy |
|
|||||
|
2014
Q1 | $47.4M | Buy |
|
|||||
|
2013
Q4 | $19.1M | Buy |
|
|||||
|
2013
Q3 | $6.61M | Buy |
|
|||||
|
2013
Q2 | $7.44M | Buy |
|